Cargando…

Photodynamic Therapy Using Hippo Pathway Inhibitor Verteporfin: A Potential Dual Mechanistic Approach in Treatment of Soft Tissue Sarcomas

SIMPLE SUMMARY: Advanced sarcomas have yet to undergo improved outcomes seen in other cancer subtypes. Verteporfin has the potential to show landmark change in sarcoma due to its anti-proliferative properties: inhibition of the Hippo pathway and as photodynamic therapy. The effect of verteporfin on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rytlewski, Jeffrey D., Scalora, Nicholas, Garcia, Keith, Tanas, Munir, Toor, Fatima, Miller, Benjamin, Allen, Bryan, Milhem, Mohammed, Monga, Varun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915813/ https://www.ncbi.nlm.nih.gov/pubmed/33567506 http://dx.doi.org/10.3390/cancers13040675

Ejemplares similares

Turning ‘Cold’ tumors ‘Hot’: immunotherapies in sarcoma
por: Rytlewski, Jeff, et al.
Publicado: (2021)

Epigenetic modulation in sensitizing metastatic sarcomas to therapies and overcoming resistance
por: Rytlewski, Jeff, et al.
Publicado: (2022)

Patient reported quality of life in young adults with sarcoma receiving care at a sarcoma center
por: Day, Jonathan R., et al.
Publicado: (2022)

A Phase I/II Study Targeting Angiogenesis Using Bevacizumab Combined with Chemotherapy and a Histone Deacetylase Inhibitor (Valproic Acid) in Advanced Sarcomas
por: Monga, Varun, et al.
Publicado: (2018)

Mid-infrared absorption by soft tissue sarcoma and cell ablation utilizing a mid-infrared interband cascade laser
por: Larson, Eric, et al.
Publicado: (2021)

Photodynamic Therapy with Verteporfin for Corneal Neovascularization
por: Al-Torbak, Abdullah A.
Publicado: (2012)

Verteporfin suppresses osteosarcoma progression by targeting the Hippo signaling pathway
por: Yang, Xianliang, et al.
Publicado: (2021)

A comprehensive evaluation of Hippo pathway silencing in sarcomas
por: Merritt, Nicole M., et al.
Publicado: (2018)

Intratumoral talimogene laherparepvec injection with concurrent preoperative radiation in patients with locally advanced soft-tissue sarcoma of the trunk and extremities: phase IB/II trial
por: Monga, Varun, et al.
Publicado: (2021)

CDKs in Sarcoma: Mediators of Disease and Emerging Therapeutic Targets
por: Kohlmeyer, Jordan L, et al.
Publicado: (2020)

Photodynamic Therapy With Verteporfin for Choroidal Neovascularization in Patients with Angioid Streaks
por: Lee, Jun Mok, et al.
Publicado: (2007)

Red Upconverter Nanocrystals Functionalized with Verteporfin for Photodynamic Therapy Triggered by Upconversion
por: Miletto, Ivana, et al.
Publicado: (2022)

Neoadjuvant Radiotherapy-Related Wound Morbidity in Soft Tissue Sarcoma: Perspectives for Radioprotective Agents
por: Callaghan, Cameron M., et al.
Publicado: (2020)

Verteporfin photodynamic therapy of retinal capillary hemangioblastoma in von Hippel-Lindau disease
por: Bhattacharjee, Harsha, et al.
Publicado: (2010)

Retinal Capillary Hemangioma Treated with Verteporfin Photodynamic Therapy and Intravitreal Triamcinolone Acetonide
por: Suh, Shin Cho, et al.
Publicado: (2007)

Comparison of Focal and Conventional Verteporfin Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
por: Noh, Sung Rae, et al.
Publicado: (2019)

Verteporfin inhibits YAP-induced bladder cancer cell growth and invasion via Hippo signaling pathway
por: Dong, Liang, et al.
Publicado: (2018)

Video monitoring of neovessel occlusion induced by photodynamic therapy with verteporfin (Visudyne(®)), in the CAM model
por: Debefve, E., et al.
Publicado: (2008)

Verteporfin photodynamic therapy combined with intravitreal triamcinolone for choroidal neovascularization due to angioid streaks
por: Pece, Alfredo, et al.
Publicado: (2010)

Macular sensitivity after half-dose verteporfin photodynamic therapy in central serous chorioretinopathy
por: Sanguansak, Thuss, et al.
Publicado: (2015)

Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer
por: Huggett, M T, et al.
Publicado: (2014)

Photodynamic Therapy with Verteporfin for Chronic Central Serous Chorioretinopathy: A Review of Data and Efficacy
por: Iacono, Pierluigi, et al.
Publicado: (2020)

Photoproducts of the Photodynamic Therapy Agent Verteporfin Identified via Laser Interfaced Mass Spectrometry
por: Furlan, Chris, et al.
Publicado: (2020)

Verteporfin-Loaded Lipid Nanoparticles Improve Ovarian Cancer Photodynamic Therapy In Vitro and In Vivo
por: Michy, Thierry, et al.
Publicado: (2019)

A Retrospective Analysis of the Efficacy of Immunotherapy in Metastatic Soft-Tissue Sarcomas
por: Monga, Varun, et al.
Publicado: (2020)

A case of presumed choroidal metastasis from carcinoid tumor treated by photodynamic therapy with verteporfin
por: Kawakami, Setsuko, et al.
Publicado: (2013)

Ranibizumab, Verteporfin Photodynamic Therapy or Observation for the Treatment of Myopic Choroidal Neovascularization: Cost Effectiveness in the UK
por: Claxton, Lindsay, et al.
Publicado: (2014)

Long-term outcomes in half-dose verteporfin photodynamic therapy for chronic central serous retinopathy
por: Dhirani, Nadeem Ali, et al.
Publicado: (2017)

Prognostic and therapeutic value of the Hippo pathway, RABL6A, and p53-MDM2 axes in sarcomas
por: Desai, Chandni, et al.
Publicado: (2021)

Half-dose verteporfin photodynamic therapy for bullous variant of central serous chorioretinopathy: a case report
por: Ng, Winnie WK, et al.
Publicado: (2011)

Five-year results of photodynamic therapy with verteporfin for Japanese patients with neovascular age-related macular degeneration
por: Tsuchihashi, Takashi, et al.
Publicado: (2013)

A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas
por: Deel, Michael D., et al.
Publicado: (2015)

Functional Profiling of Soft Tissue Sarcoma Using Mechanistic Models
por: Payá-Milans, Miriam, et al.
Publicado: (2023)

Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy
por: Alkin, Zeynep, et al.
Publicado: (2014)

Verteporfin Photodynamic Therapy Combined with Intravitreal Ranibizumab for Polypoidal Choroidal Vasculopathy Controversy Concerning Long-Term Followup
por: Fernández, Maribel, et al.
Publicado: (2012)

The Noninvasive Treatment for Sentinel Lymph Node Metastasis by Photodynamic Therapy Using Phospholipid Polymer as a Nanotransporter of Verteporfin
por: Shimada, Kyosuke, et al.
Publicado: (2017)

Comparison of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: The EVEREST II Randomized Clinical Trial
por: Lim, Tock H., et al.
Publicado: (2020)

Genetic Alterations and Deregulation of Hippo Pathway as a Pathogenetic Mechanism in Bone and Soft Tissue Sarcoma
por: Salguero-Aranda, Carmen, et al.
Publicado: (2022)

Verteporfin Inhibits the Progression of Spontaneous Osteosarcoma Caused by Trp53 and Rb1 Deficiency in Ctsk-Expressing Cells via Impeding Hippo Pathway
por: Li, Yang, et al.
Publicado: (2022)

Combination verteporfin photodynamic therapy ranibizumab-dexamethasone in choroidal neovascularization due to age-related macular degeneration: results of a phase II randomized trial
por: Gallemore, Ron P, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bcvmu9vg94cuik7kf02p0e1di1